The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 29, 2018

Filed:

Apr. 17, 2013
Applicant:

Eisai R&d Management Co., Ltd., Tokyo, JP;

Inventor:

Yosuke Ueki, Gifu, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/38 (2006.01); A61K 47/26 (2006.01); A61K 47/36 (2006.01); A61K 31/675 (2006.01); A61K 47/32 (2006.01); A61K 9/48 (2006.01); A61K 31/661 (2006.01); A61K 47/02 (2006.01);
U.S. Cl.
CPC ...
A61K 47/38 (2013.01); A61K 9/4816 (2013.01); A61K 9/4858 (2013.01); A61K 9/4891 (2013.01); A61K 31/661 (2013.01); A61K 31/675 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01); A61K 47/36 (2013.01); A61K 47/02 (2013.01);
Abstract

An object of the present invention is to provide a capsule formulation comprising a phosphonooxymethyl derivative of ravuconazole which suppresses delay in dissolution due to storage regardless of an encapsulated amount of the phosphonooxymethyl derivative of ravuconazole. The present invention provides a capsule formulation comprising an encapsulated material comprising {[(1R,2R)-2-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-1-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-ylmethyl)propyl]oxy}methyl dihydrogen phosphate or a pharmacologically acceptable salt thereof, or a solvate of any of the foregoing, and a capsule shell not comprising gelatin.


Find Patent Forward Citations

Loading…